- ICPT has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $73.8 million.
- ICPT traded 38,867 shares today in the pre-market hours as of 8:19 AM, representing 11% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ICPT with the Ticky from Trade-Ideas. See the FREE profile for ICPT NOW at Trade-Ideas More details on ICPT: Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry. ICPT has a PE ratio of 48.9. Currently there are 6 analysts that rate Intercept Pharmaceuticals a buy, 1 analyst rates it a sell, and none rate it a hold. The average volume for Intercept Pharmaceuticals has been 500,400 shares per day over the past 30 days. Intercept has a market cap of $5.5 billion and is part of the health care sector and drugs industry. The stock has a beta of -5.67 and a short float of 10.3% with 2.87 days to cover. Shares are up 260.2% year-to-date as of the close of trading on Wednesday.